Daptomycin pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy

Crit Care Med. 2011 May;39(5):1243-4; author reply 1244-5. doi: 10.1097/CCM.0b013e31820f6d58.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Infective Agents / pharmacokinetics*
  • Anti-Infective Agents / therapeutic use
  • Critical Illness / mortality
  • Critical Illness / therapy
  • Daptomycin / pharmacokinetics*
  • Daptomycin / therapeutic use
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Hospital Mortality
  • Humans
  • Infusions, Intravenous
  • Intensive Care Units
  • Male
  • Renal Dialysis / adverse effects
  • Renal Dialysis / methods*
  • Risk Assessment
  • Survival Rate
  • Treatment Outcome

Substances

  • Anti-Infective Agents
  • Daptomycin